Irpagratinib (ABSK011) is an orally active and highly effective FGFR4 antagonist with antitumor activity, inhibiting FGFR4 autophosphorylation and blocking FGFR4 signaling to downstream pathways. It is used in studies of gastrointestinal diseases and cancer.
Molecular Weight:
570.59
Purity:
99.38%
CAS Number:
[2230974-62-4]
Formula:
C28H32F2N6O5
Target:
FGFR
T79850
* VAT and and shipping costs not included. Errors and price changes excepted